Dendritic Cell Vaccine in HIV-1 Infection

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
HIV Infections
Interventions
BIOLOGICAL

Dendritic cell vaccine

107 DC subcutaneous 3 doses every 2 weeks

BIOLOGICAL

non pulsed dendritic cell untreated patients

107 DC subcutaneous 3 doses every 2 weeks

BIOLOGICAL

pulsed dendritic cell vaccine

107 DC subcutaneous 3 doses every 2 weeks

BIOLOGICAL

dendritic cell vaccine

107 DC subcutaneous 3 doses every 2 weeks

BIOLOGICAL

non pulsed dendritic cell vaccine

107 DC subcutaneous 3 doses every 2 weeks

Trial Locations (1)

08036

Hospital Clínic, Barcelona

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER

NCT00402142 - Dendritic Cell Vaccine in HIV-1 Infection | Biotech Hunter | Biotech Hunter